1. Alzheimer’s Disease International. World Alzheimer report 2018: the state of the art of dementia research: new frontiers. London: Alzheimer’s Disease International; 2018.
2. Suh GH. Dementia in Korea: trend and projection. J Korean Geriatr Psychiatry 2002;6:79–87.
4. Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, Loewenstein D, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord 2002;16:203–212.
5. Jorm AF, Jolley D. The incidence of dementia: a meta-analysis. Neurology 1998;51:728–733.
6. Alzheimer’s Association. 2016 Alzheimer’s disease facts and figures. Alzheimers Dement 2016;12:459–509.
7. Geldmacher DS, Whitehouse PJ. Evaluation of dementia. N Engl J Med 1996;335:330–336.
8. Alexopoulos P, Greim B, Nadler K, Martens U, Krecklow B, Domes G, et al. Validation of the Addenbrooke’s cognitive examination for detecting early Alzheimer’s disease and mild vascular dementia in a German population. Dement Geriatr Cogn Disord 2006;22:385–391.
9. Giebel CM, Burns A, Challis D. Taking a positive spin: preserved initiative and performance of everyday activities across mild Alzheimer’s, vascular and mixed dementia. Int J Geriatr Psychiatry 2017;32:959–967.
10. Rocca WA, Hofman A, Brayne C, Breteler MM, Clarke M, Copeland JR, et al. The prevalence of vascular dementia in Europe: facts and fragments from 1980-1990 studies. Ann Neurol 1991;30:817–824.
11. Tierney MC, Black SE, Szalai JP, Snow WG, Fisher RH, Nadon G, et al. Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia. Arch Neurol 2001;58:1654–1659.
13. Román GC. Vascular dementia: distinguishing characteristics, treatment, and prevention. J Am Geriatr Soc 2003;51(5 Suppl 2):S296–S304.
14. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566–572.
15. Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology 1993;43:2412–2414.
16. Chaves ML, Camozzato AL, Godinho C, Kochhann R, Schuh A, de Almeida VL, et al. Validity of the clinical dementia rating scale for the detection and staging of dementia in Brazilian patients. Alzheimer Dis Assoc Disord 2007;21:210–217.
18. Rosness TA, Haugen PK, Engedal K. The clinical dementia rating scale could be helpful in differentiating frontotemporal dementia from Alzheimer’s disease. Int J Geriatr Psychiatry 2011;26:879–880.
19. Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, Kim JH, et al. Development of the Korean version of the consortium to establish a registry for Alzheimer’s disease assessment packet (CERAD-K): clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci 2002;57:P47–P53.
20. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7:486–488.
21. Cho MJ, Bae JN, Suh GH, Hahm BJ, Kim JK, Lee DW, et al. Validation of geriatric depression scale, Korean version(GDS) in the assessment of DSM-III-R major depression. J Korean Neuropsychiatr Assoc 1999;38:48–63.
22. Seo EH, Lee DY, Choo IH, Kim SG, Kim KW, Youn JC, et al. Normative study of the Stroop color and word test in an educationally diverse elderly population. Int J Geriatr Psychiatry 2008;23:1020–1027.
23. Kim TH, Huh Y, Choe JY, Jeong JW, Park JH, Lee SB, et al. Korean version of frontal assessment battery: psychometric properties and normative data. Dement Geriatr Cogn Disord 2010;29:363–370.
24. Kim SG, Lee DY, Seo EH, Choo IH, Kim JW, Do YJ, et al. A normative study of an executive clock drawing task(CLOX) in Korean elderly. J Korean Neuropsychiatr Assoc 2009;48:437–446.
25. Gélinas I, Gauthier L, McIntyre M, Gauthier S. Development of a functional measure for persons with Alzheimer’s disease: the disability assessment for dementia. Am J Occup Ther 1999;53:471–481.
26. Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC, et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer’s disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 1998;55:326–335.
27. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58:397–405.
28. Fillenbaum GG, Peterson B, Morris JC. Estimating the validity of the clinical dementia rating scale: the CERAD experience. Aging Clin Exp Res 1996;8:379–385.
29. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology 1993;43:250–260.
30. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDSADRDA work group under the auspices of department of health and human services task force on Alzheimer’s disease. Neurology 1984;34:939–944.
31. Looi JC, Sachdev PS. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology 1999;53:670
32. Román GC, Royall DR. Executive control function: a rational basis for the diagnosis of vascular dementia. Alzheimer Dis Assoc Disord 1999;13(Suppl 3):S69–S80.
33. Prince M, Wimo A, Guerchet M, Ali GC, Wu YT, Prina M. World Alzheimer report 2015: the global impact of dementia. London: Alzheimer’s Disease International; 2015, p. 25–46.
34. Kim KW, Park JH, Kim MH, Kim MD, Kim BJ, Kim SK, et al. A nationwide survey on the prevalence of dementia and mild cognitive impairment in South Korea. J Alzheimers Dis 2011;23:281–291.
35. Andersen K, Launer LJ, Dewey ME, Letenneur L, Ott A, Copeland JR, et al. Gender differences in the incidence of AD and vascular dementia: the EURODEM studies. Neurology 1999;53:1992
37. Burke WJ, Miller JP, Rubin EH, Morris JC, Coben LA, Duchek J, et al. Reliability of the Washington university clinical dementia rating. Arch Neurol 1988;45:31–32.
38. McCulla MM, Coats M, Van Fleet N, Duchek J, Grant E, Morris JC. Reliability of clinical nurse specialists in the staging of dementia. Arch Neurol 1989;46:1210–1211.
39. Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 1997;9(Suppl 1):173–176.
40. O’Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, et al. Vascular cognitive impairment. Lancet Neurol 2003;2:89–98.
41. Stebbins GT, Nyenhuis DL, Wang C, Cox JL, Freels S, Bangen K, et al. Gray matter atrophy in patients with ischemic stroke with cognitive impairment. Stroke 2008;39:785–793.
42. Desmond DW. The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit? J Neurol Sci 2004;226:3–7.
43. Graham NL, Emery T, Hodges JR. Distinctive cognitive profiles in Alzheimer’s disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry 2004;75:61–71.
44. Kertesz A, Clydesdale S. Neuropsychological deficits in vascular dementia vs Alzheimer’s disease. Frontal lobe deficits prominent in vascular dementia. Arch Neurol 1994;51:1226–1231.
45. Tekin S, Fairbanks LA, O’Connor S, Rosenberg S, Cummings JL. Activities of daily living in Alzheimer’s disease: neuropsychiatric, cognitive, and medical illness influences. Am J Geriatr Psychiatry 2001;9:81–86.
46. O’Bryant SE, Falkowski J, Hobson V, Johnson L, Hall J, Schrimsher GW, et al. Executive functioning mediates the link between other neuropsychological domains and daily functioning: a project FRONTIER study. Int Psychogeriatr 2011;23:107–113.
47. Lezak MD, Howieson DB, Loring DW. Neuropsychological assessment (4th ed). New York: Oxford University Press; 2004.